Persistent Asset Partners »

Apogee Therapeutics shares owned by Persistent Asset Partners

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Persistent Asset Partners from 13F filings

Historical chart of Persistent Asset Partners investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Persistent Asset Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Persistent Asset Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $589k 15k 39.73

More positions owned by Persistent Asset Partners

Centene Corporation (CNC)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
UnitedHealth (UNH)
Regeneron Pharmaceuticals (REGN)
CVS Caremark Corporation (CVS)
Nebius Group Shs Class A (NBIS)
Pdd Holdings Sponsored Ads (PDD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Soleno Therapeutics (SLNO)
BioMarin Pharmaceutical (BMRN)
Labcorp Holdings Com Shs (LH)
Anthem (ELV)
Healthcare Services (HCSG)
Quest Diagnostics Incorporated (DGX)
Brightspring Health Svcs (BTSG)

View all positions for Persistent Asset Partners

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
Rtw Investments
BlackRock
Vanguard Group
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Paradigm Biocapital Advisors
Braidwell
Alliancebernstein
Perceptive Advisors
Citadel Advisors
Affinity Asset Advisors

View all funds holding Apogee Therapeutics